4.5 Article

Regional control after precision lymph node dissection for clinically evident melanoma metastasis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Alexander C. J. van Akkooi et al.

Summary: Exciting advances in melanoma systemic therapies have provided opportunities for neoadjuvant systemic treatment in high-risk, resectable metastatic melanomas. This article presents the current state of neoadjuvant systemic therapy for melanoma, focusing on the surgical aspects and the role of surgical oncologists. It summarizes past developments in melanoma treatment and the evidence for neoadjuvant systemic therapy in stage III melanoma, discussing surgical issues, technical aspects, and other important considerations.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

James W. Jakub et al.

Summary: This study retrospectively analyzed the oncologic outcomes of minimally invasive inguinal lymphadenectomy (MILND) in patients with melanoma. The results showed that MILND is safe and has favorable oncologic outcomes compared to traditional open inguinal lymphadenectomy (OILND).

ANNALS OF SURGICAL ONCOLOGY (2022)

Review Surgery

Primary Prevention of Cancer-Related Lymphedema Using Preventive Lymphatic Surgery: Systematic Review and Meta-analysis

Pedro Ciudad et al.

Summary: Prophylactic lymphatic surgery can potentially reduce the risk of cancer-related lymphedema.

INDIAN JOURNAL OF PLASTIC SURGERY (2022)

Article Biochemistry & Molecular Biology

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

Irene L. M. Reijers et al.

Summary: Neoadjuvant ipilimumab and nivolumab induce high pathologic response rates in clinical stage III nodal melanoma, with potential for treatment personalization based on pathologic response.

NATURE MEDICINE (2022)

Article Biochemistry & Molecular Biology

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

Alexander C. Huang et al.

NATURE MEDICINE (2019)

Article Biochemistry & Molecular Biology

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Rodabe N. Amaria et al.

NATURE MEDICINE (2018)

Article Biochemistry & Molecular Biology

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Christian U. Blank et al.

NATURE MEDICINE (2018)

Article Oncology

Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema

Caroline A. Gjorup et al.

EUROPEAN JOURNAL OF CANCER (2017)

Article Medicine, General & Internal

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

M. B. Faries et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Orthopedics

Complications following inguinal and ilioinguinal lymphadenectomies: a meta-analysis

Martin Soderman et al.

JOURNAL OF PLASTIC SURGERY AND HAND SURGERY (2016)

Article Surgery

Risk factors associated with lymphedema after lymph node dissection in melanoma patients

Jeffrey F. Friedman et al.

AMERICAN JOURNAL OF SURGERY (2015)